Autors:

CiteWeb id: 20020000126

CiteWeb score: 4541

DOI: 10.1016/S0140-6736(02)08512-4

We did a randomised controlled trial to assess the benefit of maintenance infliximab therapy in patients with active Crohn's disease who respond to a single infusion of infliximab.

The publication "Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial" is placed in the Top 10000 of the best publications in CiteWeb. Also in the category Medicine it is included to the Top 1000. Additionally, the publicaiton "Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial" is placed in the Top 1000 among other scientific works published in 2002.
Links to full text of the publication: